Secbutonitazene
| Secbutonitazene | |
|---|---|
| Molecular structure drawn from PubChem coordinates |
| Physical properties [] | |
|---|---|
| Molecular mass | 424.50 g/mol [1] |
| Predicted LogP | 5.2 [1] |
| Structural Identifiers [] | |
|---|---|
| Molecular formula | C24H32N4O3 |
| IUPAC name | 2-[2-[(4-butan-2-yloxyphenyl)methyl]-5-nitrobenzimidazol-1-yl]-N,N-diethylethanamine |
| SMILES | CCC(C)OC1=CC=C(C=C1)CC2=NC3=C(N2CCN(CC)CC)C=CC(=C3)[N+](=O)[O-] |
| InChI | InChI=1S/C24H32N4O3/c1-5-18(4)31-21-11-8-19(9-12-21)16-24-25-22-17-20(28(29)30)10-13-23(22)27(24)15-14-26(6-2)7-3/h8-13,17-18H,5-7,14-16H2,1-4H3 |
| InChIKey | NOIMENQCHUDEKZ-UHFFFAOYSA-N |
| PubChem CID | 168322285 |
Secbutonitazene (also known as sec-Butonitazene (citrate) or sec-Butonitazene) is a opioid substance of the aniline, benzimidazole and nitazene class.
Chemistry
Stereochemistry []
Secbutonitazene is a racemic mixture of the enantiomers.
Druglikeness
Lipinski's rule of five
Secbutonitazene matches Lipinski's rule of five (violations: 1).Subjective effects []
External links []
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 168322285, Secbutonitazene. Accessed November 20, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/168322285
Data sources []
| Source | Status | Updated (UTC) |
|---|---|---|
| dosing | missing (no dosing statistics) | 2026-11-20 17:00:47 |
| drugspro | missing (no DrugsPRO reagent data) | 2026-11-20 17:00:43 |
| erowid | missing (no Erowid substance of that name) | 2026-11-20 17:00:43 |
| gsrs | missing (no UNII) | 2026-11-20 17:00:43 |
| hmdb | missing (no HMDB id) | 2026-11-20 17:00:43 |
| kegg | missing (no KEGG DRUG entry) | 2026-11-20 17:00:45 |
| pubchem | ok | 2026-11-20 17:00:42 |
| missing (no r/tripreports posts mention it) | 2026-11-20 17:00:43 | |
| sider | missing (not in SIDER) | 2026-11-20 17:00:43 |
| structure | ok | 2026-11-20 17:00:43 |
| wikipedia | ok | 2026-11-20 17:00:43 |